Novel Potential Therapeutics for Schizophrenia: Focus on the Modulation of Metabotropic Glutamate Receptor Function
Journal:
Current Neuropharmacology
Volume:
3
Page:
9-34
Author(s):
Laura E. Chavez-Noriega, Michael J. Marino, Herve Schaffhauser, Una C. Campbell and P. Jeffrey Conn
FMRI in Pediatric Neurodevelopmental Disorders
Journal:
Current Pediatric Reviews
Volume:
1
Page:
17-24
Author(s):
Michael Seyffert and Raul Silva
Platelet MAO and Personality - Function and Dysfunction
Journal:
Current Medicinal Chemistry
Volume:
11
Page:
2007-2016
Author(s):
L. Oreland, J. Hallman and M. Damberg
The MAPK / JNK Signalling Pathway Offers Potential Therapeutic Targets for the Prevention of Acquired Deafness
Journal:
Current Drug Targets - CNS & Neurological Disorders
Volume:
3
Page:
325-332
Author(s):
A. Zine and T. R. Van De Water
Methods for Providing Therapeutic Agents to Treat Damaged Spiral Ganglion Neurons
Journal:
Current Drug Targets - CNS & Neurological Disorders
Volume:
3
Page:
195-199
Author(s):
L. M. Bianchi and Y. Raz
Muscarinic Cholinergic Contribution to Memory Consolidation: With Attention to Involvement of the Basolateral Amygdala
Journal:
Current Medicinal Chemistry
Volume:
11
Page:
987-996
Author(s):
A. E. Power
Islet-Brain (IB)/JNK-Interacting Proteins (JIPs): Future Targets for the Treatment of Neurodegenerative Diseases?
Journal:
Current Neurovascular Research
Volume:
1
Page:
111-127
Author(s):
Nathalie Moulin and Christian Widmann
The Identification and Characterization of Excitotoxic Nerve-endings in Alzheimer Disease
Journal:
Current Alzheimer Research
Volume:
1
Page:
11-25
Author(s):
Rudi K. Tannenberg, Heather L. Scott, Robert I. Westphalen and Peter R. Dodd
5-HT2 Receptors
Journal:
Current Drug Targets - CNS & Neurological Disorders
Volume:
3
Page:
11-26
Author(s):
J E Leysen
Functional Neurochemistry of Alzheimers Disease
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
265-293
Author(s):
Wieland Gsell, Gerd Jungkunz and Peter Riederer